PTC
PRCT icon

Private Trust Company’s Procept Biorobotics PRCT Stock Holding History

Private Trust Company’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45 Hold
2
– – ﹤0.01% 2688
2026
Q1 		$50 Hold
2
– – ﹤0.01% 2592
2025
Q4 		$63 Hold
2
– – ﹤0.01% 2531
2025
Q3 		$71 Buy
+2
New +$91 ﹤0.01% 2548

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Private Trust Company's PRCT Position: Q2 2026 in Review

Private Trust Company held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 2 shares worth $45. The position accounts for ﹤0.01% of the portfolio, ranked #2688.

Private Trust Company first reported a position in PRCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $71 in Q3 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Private Trust Company held 2 shares of Procept Biorobotics worth $45 as of Q2 2026.
  • Private Trust Company left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2688 holding.
  • Private Trust Company first reported a position in Procept Biorobotics in Q3 2025 and has held it in 4 quarters since.
  • Private Trust Company's Procept Biorobotics position peaked at $71 in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.